Chemily, Llc

Description

• Chemily, LLC is a research, development and consulting company focusing on cost-effective synthesis of glycan libraries, carbohydrate-based biochemicals, reagents and pharmaceuticals. CHEMILY is aiming at developing into a major supplier for carbohydrate-based biochemicals, reagents and pharmaceuticals, and has been manufacturing several categories of products using it's proprietary chemo-enzymatic and in vivo bioengineering technology. Some of the new developments include: 1.Structure-defined oligosaccharides and glycolipids; 2.Immunogenic bacterial cell surface polysaccharides; 3.Sugar nucleotides and their derivatives; 4.Carbohydrate-based pharmaceuticals and glycoprotein vaccines; 5.Carbohydrate related enzymes, such as glycosyl transferases, glycosyl hydrolases, sugar nucleotide biosynthesized enzymes. Based on its proprietary carbohydrate and uncommon sugar library (deposits), CHEMILY has been developing sugar-containing small molecules in therapeutic treatment options in two core disease areas: cancer and cardiovascular diseases. Recently, CHEMILY has been licensing and developing novel glycoconjugation technology in order to produce polysaccharide-protein conjugate vaccines and therapeutic glycoproteins to unprecedented cost effective levels.
• 

  Headquarters:58 Edgewood Avenue Northeast Suite 123, Atlanta, Georgia, United States

  More
• 

  Phone Number: +1 404-839-1996

• 

  Website: https://www.chemilyus.com

• 

  Employees:7

• 

  Revenue:$1 - 10M

• 

  Legal Name:Chemily, Llc

• Chemily, Llc's Social Media

  
• Is this data correct?

• |  NAICS Code: 541713  |

  Show More